Concordance of DLQI and pain score in hidradenitis suppurativa clinical trials: a systematic review
Background:. Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory condition and is associated with significant psychosocial impacts on patient quality of life. Objective:. This study aimed to characterize the utilization of patient-reported outcomes (PROs) in HS clinical trials and the...
Saved in:
| Main Authors: | Adina Greene, BA, Angelina S. Hwang, MD, Sarah Amjad, BS, Jacob A. Kechter, MD, Aaron R. Mangold, MD, Stella X. Chen, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-06-01
|
| Series: | International Journal of Women's Dermatology |
| Online Access: | http://journals.lww.com/10.1097/JW9.0000000000000204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient Tool for hidradenitis suppurativa specialty clinics
by: Zachary Wendland, MD, MPH, et al.
Published: (2025-04-01) -
Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01) -
A Novel Treatment of Hidradenitis Suppurativa With Radical Unroofing and Deepithelialization
by: Dylan G. Choi, BS, et al.
Published: (2025-08-01) -
Racial Disparities in Hidradenitis Suppurativa Management at a Single Institution
by: Nikhi P. Singh, MD, MBA, et al.
Published: (2025-06-01) -
Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis
by: Suma V. Gangidi, BS, et al.
Published: (2024-10-01)